share_log

424B5: Prospectus

424B5: Prospectus

424B5：募资说明书
美股SEC公告 ·  07/11 09:03
Moomoo AI 已提取核心信息
SeaStar Medical Holding Corporation, a medical technology company, has announced a registered direct offering of 947,868 shares of its common stock at a price of $10.55 per share. The offering is accompanied by a concurrent private placement of unregistered common stock purchase warrants, exercisable at $10.55, immediately upon issuance and expiring five years from the date of issuance. The purchase price for each share of common stock is also set at $10.55. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, which is expected to close on or about July 11, 2024, subject to customary closing conditions. The proceeds, before expenses, are estimated to be approximately $9.3 million and are intended for the redemption and repayment of certain notes, as well as funding the company's development and commercialization activities and general corporate purposes. This offering follows SeaStar Medical's recent compliance with Nasdaq's minimum market value requirement and its ongoing efforts to maintain its listing on the exchange.
SeaStar Medical Holding Corporation, a medical technology company, has announced a registered direct offering of 947,868 shares of its common stock at a price of $10.55 per share. The offering is accompanied by a concurrent private placement of unregistered common stock purchase warrants, exercisable at $10.55, immediately upon issuance and expiring five years from the date of issuance. The purchase price for each share of common stock is also set at $10.55. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, which is expected to close on or about July 11, 2024, subject to customary closing conditions. The proceeds, before expenses, are estimated to be approximately $9.3 million and are intended for the redemption and repayment of certain notes, as well as funding the company's development and commercialization activities and general corporate purposes. This offering follows SeaStar Medical's recent compliance with Nasdaq's minimum market value requirement and its ongoing efforts to maintain its listing on the exchange.
医疗技术公司SeaStar Medical Holding Corporation宣布以每股10.55美元的价格发行947,868股普通股的注册直接发行。发行伴随着认购无注册普通股购买权的定向增发，认购价为10.55美元，发行后即可行使，有效期为发行之日起五年。每股普通股的购买价格也定为10.55美元。H.C.Wainwright＆Co.担任本次发行的独家配售代理，预计将于2024年7月11日左右结束，视乎惯例交割条件。扣除费用后，净收益约为930万美元，用于赎回和还款某些票据，以及资助公司的开发和商业化活动及一般公司用途。此次发行是SeaStar Medical近期达到纳斯达克股票交易所的最低市值要求以及保持其上市地位的持续努力之后的产物。
医疗技术公司SeaStar Medical Holding Corporation宣布以每股10.55美元的价格发行947,868股普通股的注册直接发行。发行伴随着认购无注册普通股购买权的定向增发，认购价为10.55美元，发行后即可行使，有效期为发行之日起五年。每股普通股的购买价格也定为10.55美元。H.C.Wainwright＆Co.担任本次发行的独家配售代理，预计将于2024年7月11日左右结束，视乎惯例交割条件。扣除费用后，净收益约为930万美元，用于赎回和还款某些票据，以及资助公司的开发和商业化活动及一般公司用途。此次发行是SeaStar Medical近期达到纳斯达克股票交易所的最低市值要求以及保持其上市地位的持续努力之后的产物。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息